Letter to the editor: "Primary" hypophysitis and the benefits of glucocorticoids, a still unresolved question

Affiliations

¹ Service de Médecine Interne et d'Immunologie Clinique, Hôpital de La Conception, Assistance Publique Hôpitaux de Marseille (AP-HM), Marseille, France.
² Department of Neuroradiology, La Conception Hospital, Marseille, France.
³ Aix Marseille Université, INSERM U1251, Marseille Medical Geneticas, Marmara Institute, Department of Endocrinology, Assistance Publique Hôpitaux de Marseille (AP-HM), Hôpital de La Conception, CRMR HYPO, Marseille, France.

Editorial

Léa Miquel et al. Eur J Endocrinol. 2025.

. 2025 Jan 6;192(1):L1-L2.

doi: 10.1093/ejendo/lvae164.

¹ Service de Médecine Interne et d'Immunologie Clinique, Hôpital de La Conception, Assistance Publique Hôpitaux de Marseille (AP-HM), Marseille, France.
² Department of Neuroradiology, La Conception Hospital, Marseille, France.
³ Aix Marseille Université, INSERM U1251, Marseille Medical Geneticas, Marmara Institute, Department of Endocrinology, Assistance Publique Hôpitaux de Marseille (AP-HM), Hôpital de La Conception, CRMR HYPO, Marseille, France.

No abstract available

Keywords: glucocorticoids; hypophysitis; pituitary deficiency; sarcoidosis.

Conflict of interest statement

Conflict of interest: None declared.

Response to commentary: "Primary hypophysitis and the benefits of glucocorticoids, a still unresolved question".
Hacioglu A, Karaca Z, Unluhizarci K, Kelestimur F. Hacioglu A, et al. Eur J Endocrinol. 2025 Jan 6;192(1):L3-L4. doi: 10.1093/ejendo/lvae165. Eur J Endocrinol. 2025. PMID: 39699196 No abstract available.

Response to commentary: "Primary hypophysitis and the benefits of glucocorticoids, a still unresolved question".
Hacioglu A, Karaca Z, Unluhizarci K, Kelestimur F. Hacioglu A, et al. Eur J Endocrinol. 2025 Jan 6;192(1):L3-L4. doi: 10.1093/ejendo/lvae165. Eur J Endocrinol. 2025. PMID: 39699196 No abstract available.